Dr. Michael John Bax, MD

Dr. Bax practices at Roswell Park Cancer Institute in Los Angeles, California.

Dr. Bax's NPI, 1740589274, was assigned on March 23, 2011. Dr. Bax holds New York license 265705.

Dr. Bax's primary practice is Roswell Park Cancer Institute, at 344 S Hauser Blvd, Los Angeles, CA 90036 in Los Angeles County. The practice phone is (716) 845-2300.

Dr. Bax's primary practice is Roswell Park Cancer Institute in Los Angeles, California. Dr. Bax is also affiliated with Roswell Park Comprehensive Cancer Center. The medical group on file is Roswell Park Comprehensive Cancer Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bax practices. Vendor and product names are available with a free account.

Dermatology is Dr. Bax's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Bax is licensed in New York.

CMS data shows 366 Medicare services from Dr. Bax across 11 procedure codes in 2024, for 186 Medicare patients. Medicare paid $54,698 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 186 Medicare patients who saw Dr. Bax in 2024. The largest group is 75 to 84, with 75 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 14% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Bax's median patient age at 77, with 40% women.

In 2024, Dr. Bax wrote 100 Medicare Part D claims for 78 patients. 96% of them were for generic drugs. CMS names the drug for 67 of them, across 3 drugs with 11 or more claims each, at $798 in total drug cost. In 2023, CMS named 139 claims across 5 drugs.

Dr. Bax accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 97 procedures of melanoma (skin cancer) excision by Dr. Bax, more than 93% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal or shaving of skin growth: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 14 general payments to Dr. Bax from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $621.